Low Libido: Symptoms and Treatment
A meaningful drop in sexual desire through your 40s and 50s is rarely about willpower or relationship friction alone. Estradiol, progesterone, and testosterone all influence libido, and all three shift through perimenopause.
What Causes Low Libido in Perimenopause?
Sexual desire in women is multidimensional. It depends on hormonal signaling, brain reward pathways, sleep quality, mood, body image, vaginal tissue health, relationship context, and medication effects. Hormonally, estradiol supports vaginal tissue, lubrication, and sensitivity. Testosterone, the most abundant sex hormone in women by total production volume, drives the desire and arousal pathway directly. Progesterone influences sleep and anxiety, both of which feed back into desire. When all three shift through perimenopause, libido frequently changes before the woman or her partner can identify why.
The pattern most women describe is a loss of spontaneous desire, slower arousal, reduced sensitivity, and a sense that sex feels like an obligation rather than something they want. Vaginal dryness or discomfort during sex compounds the cycle, because pain or discomfort during intimacy further reduces interest. The 2022 Hormone Therapy Position Statement of The North American Menopause Society recognizes hypoactive sexual desire disorder and the genitourinary syndrome of menopause as treatable conditions, with specific evidence supporting low-dose testosterone for postmenopausal women in select cases.
For broader context on testosterone in women specifically, see our overview on testosterone for women. The clinical priority on this page is identifying the hormonal contributors and ruling out the conditions that mimic them.
Differential diagnosis matters. SSRI and SNRI antidepressants, hormonal birth control, untreated thyroid disease, depression, chronic sleep deprivation, and relationship factors all reduce libido independently of menopause. Our medical team reviews medications and screens for these factors before attributing low desire to hormones alone.
How Tactus Health Evaluates Low Libido
The evaluation begins with a structured clinical history. Our licensed providers map the timing of the change in desire against menstrual cycle changes, sleep, mood, current medications, and relationship factors. The goal is to separate hormonal contributors from the medications and conditions that mimic them, because libido changes commonly involve more than one factor.
Lab work covers estradiol, progesterone, FSH, total and free testosterone, sex hormone binding globulin, TSH, free T4, vitamin D, and a comprehensive metabolic panel. When labs and history align with hormonal contributors, our medical team builds a treatment plan that may include estradiol, progesterone, vaginal estrogen for tissue symptoms, and in select cases low-dose testosterone for desire and arousal symptoms. Treatment is monitored with follow-up labs and standardized symptom scoring.
Common Questions About Low Libido
In appropriately selected women, yes. Estradiol restores vaginal tissue and reduces pain with intimacy. Vaginal estrogen specifically improves sensitivity and lubrication. Low-dose testosterone has the strongest evidence for improving desire in postmenopausal women with diagnosed hypoactive sexual desire disorder, when other causes have been ruled out. The combination is more effective than any single hormone alone for many women, but treatment is always built around the specific clinical picture.
A hormonal pattern usually has clear timing: desire changed alongside cycle changes, hot flashes, sleep disruption, or vaginal symptoms. Other patterns point elsewhere. New antidepressant use is a common driver. Untreated depression presents with low desire alongside persistent low mood and loss of pleasure across activities. Relationship factors can be primary or secondary. A complete evaluation distinguishes between these and identifies the cases where multiple causes overlap.
A complete workup includes estradiol, progesterone, FSH, total and free testosterone, sex hormone binding globulin, TSH, free T4, and vitamin D. Sex hormone binding globulin matters because it affects how much testosterone is biologically active. Hormonal birth control raises this protein and can lower active testosterone significantly. Our medical team orders the full panel so the treatment plan reflects the complete picture.
Restore Desire. Find the Cause.
Free consultation. Complete hormonal evaluation. In-person care with our medical team in Sugar Hill, Georgia.
Not sure if your symptoms are hormonal?
Our free menopause assessment takes about three minutes. Answer 11 questions and get a read on whether your symptoms fit perimenopause or menopause, and which labs help confirm it.
Take the free assessment →Educational screening, not a diagnosis. Only a provider can confirm.